Medical resource utilization in nonhemorrhagic stroke in a commercially insured US population

被引：0
|
作者：
McCollam, PL
Ollendorf, DA
Dennett, S
机构：
[1] Pharmetr Inc, Watertown, MA USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Strateg Hlth Outcomes, Indianapolis, IN USA
来源：
STROKE | 2006年 / 37卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [11] Medication Utilization for Alcohol Use Disorder in a Commercially Insured Population
    Huskamp, Haiden A.
    Reif, Sharon
    Greenfield, Shelly F.
    Normand, Sharon-Lise T.
    Busch, Alisa B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (11) : 3262 - 3270
  • [12] Economic burden of metastatic melanoma in a commercially insured US population
    Ray, S.
    Tunceli, O.
    Ganguli, A.
    Kamat, S.
    Gu, T.
    Singer, J.
    Luo, Y.
    Xu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [13] EPIDEMIOLOGY OF GASTROINTESTINAL NEUROENDOCRINE TUMORS IN A US COMMERCIALLY INSURED POPULATION
    Broder, Michael S.
    Cai, Beilei
    Chang, Eunice
    Neary, Maureen P.
    ENDOCRINE PRACTICE, 2017, 23 (10) : 1210 - 1216
  • [14] Epidemiology of Asthma by GINA Step in a US Commercially Insured Population
    Cao, H.
    Busse, W. W.
    Fang, J.
    Marvel, J.
    Tian, H.
    Altman, P. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [15] Predictors of stroke risk associated with atrial fibrillation: Results from a large commercially insured US population
    Ollendorf, D
    Fidan, D
    Leguet, P
    Gabriel, S
    Boccuzzi, SJ
    VALUE IN HEALTH, 2005, 8 (06) : A150 - A150
  • [16] THE BURDEN OF CYSTIC FIBROSIS: PULMONARY EXACERBATIONS AND HEALTH CARE RESOURCE UTILIZATION IN A COMMERCIALLY INSURED POPULATION IN THE UNITED STATES
    Hassan, M.
    Bonafede, M. M.
    Limone, B.
    Hodgkins, P.
    Sawicki, G.
    VALUE IN HEALTH, 2016, 19 (03) : A115 - A115
  • [17] Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population
    Wallace, Anna E.
    Kaila, Shuchita
    Bayer, Valentina
    Shaikh, Asif
    Shinde, Mayura U.
    Willey, Vincent J.
    Napier, Mark B.
    Singer, Joseph R.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (02): : 205 - 217
  • [18] COMBINATION UTILIZATION PATTERNS AND TREATMENT PREDICTORS IN ADHD IN A COMMERCIALLY INSURED POPULATION
    Bernauer, M.
    Farr, A.
    Haynes, V
    Montejano, L. B.
    Lenhart, G.
    Pohl, G.
    Kelsey, D.
    VALUE IN HEALTH, 2012, 15 (04) : A84 - A85
  • [19] Utilization patterns and characteristics of users of biologic anti-inflammatory agents in a large, US commercially insured population
    Mendelsohn, Aaron B.
    Nam, Young Hee
    Marshall, James
    McDermott, Cara L.
    Kochar, Bharati
    Kappelman, Michael D.
    Brown, Jeffrey S.
    Lockhart, Catherine M.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (01):
  • [20] Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
    Flanigan, Jeanine A.
    Yasuda, Marie
    Chen, Chi-Chang
    Li, Edward C.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (06)
12345